Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
02/09/2012 | US20120034213 TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
02/09/2012 | US20120034210 Compositions for potentiating apoposis signals in tumour cells |
02/09/2012 | US20120034205 Pkc activators and anticoagulant in regimen for treating stroke |
02/09/2012 | US20120034204 Fertilization modulation compounds and process for implementing them |
02/09/2012 | US20120034202 Ameliorating agent for chronic obstructive pulmonary disease |
02/09/2012 | US20120034196 Gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof (frank) |
02/09/2012 | US20120034187 Hepatitis C Inhibitor Compounds |
02/09/2012 | US20120034186 Indoline scaffold shp-2 inhibitors and method of treating cancer |
02/09/2012 | US20120034185 Anti-cd20 antibodies and fusion proteins therof and methods of use |
02/09/2012 | US20120034184 4'-substituted nucleoside derivatives as inhibitors of hcv rna replication |
02/09/2012 | US20120034183 Compositions and methods for growing embryonic stem cells |
02/09/2012 | US20120034167 Tyrosine kinase receptor tyro3 as a therapeutic target in the treatment of cancer |
02/09/2012 | US20120034166 Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof |
02/09/2012 | US20120034164 Truncated car peptides and methods and compositions using truncated car peptides |
02/09/2012 | US20120034163 Non-invasive tools for detecting vulnerable atherosclerotic plaques |
02/09/2012 | US20120034162 Fullerene Assisted Cell Penetrating Peptides |
02/09/2012 | US20120034159 Antibodies that bind both bcma and taci |
02/09/2012 | DE102010039019A1 Antikörper gegen 6-sulfo LacNAc positive humane dendritische Zellen und deren Verwendung Antibodies against 6-sulfo LacNAc positive human dendritic cells and their use |
02/09/2012 | DE102010039018A1 Anti-La Antikörper und ihre Anwendung zum Immunotargeting Anti-La antibodies and their application to Immunotargeting |
02/09/2012 | DE102010039015A1 Linkerpeptid und seine Verwendung in Fusionsproteinen Linker peptide and its use in fusion proteins |
02/09/2012 | DE102010033458A1 Use of lectin composition for e.g. prophylaxis and/or treatment of gonadotropin releasing hormone-analogues-related adverse drug side effects, comprising emulsified lectin, and optionally further auxiliary substances and carrier substances |
02/09/2012 | CA2817925A1 Compositions and methods for detecting, diagnosing, and treating cancer |
02/09/2012 | CA2807749A1 Protein fusion constructs possessing thrombolytic and anticoagulant properties |
02/09/2012 | CA2807552A1 Engineered nucleic acids and methods of use thereof |
02/09/2012 | CA2807149A1 Novel treatment of prostate carcinoma |
02/09/2012 | CA2807043A1 Polypeptides for treating and/or limiting influenza infection |
02/09/2012 | CA2805134A1 Improved recombinant human follicle-stimulating hormone |
02/08/2012 | EP2415876A1 Highly sensitive detection method for highly virulent oral cavity bacteria |
02/08/2012 | EP2415781A1 Antigenic determinants recognized by anti-human death receptor dr5 monoclonal antibody ad5-10, derivatives and uses thereof |
02/08/2012 | EP2415780A1 Synthetic peptide and uses thereof |
02/08/2012 | EP2415480A2 Methods for Regulation of Stem Cells |
02/08/2012 | EP2415479A2 Methods for Regulation of Stem Cells |
02/08/2012 | EP2415478A1 Prophylactic or therapeutic agent for retinal diseases and method for preventing or treating retinal diseases, each comprising jnk (c-jun n-terminal kinase)-inhibiting peptide, and use of the peptide |
02/08/2012 | EP2415461A1 Stabilization of interleukin 6 in serum based solutions |
02/08/2012 | EP2414516A1 Pro-apoptotic peptides |
02/08/2012 | EP2414513A2 Compositions and methods comprising aspartyl-trna synthetases having non-canonical biological activities |
02/08/2012 | EP2414388A1 Polypeptides and use thereof for treatment of traumatic or degenerative neuronal injury |
02/08/2012 | EP2414385A2 Compositions and methods for modulating the activity of complement regulatory proteins on target cells |
02/08/2012 | EP2414382A2 Novel proteasome-activating lightening peptides and compositions containing same |
02/08/2012 | EP2414381A2 Proteasome-activating anti-aging peptides and compositions containing same |
02/08/2012 | EP2414043A1 Bmp-alk3 antagonists and uses for promoting bone growth |
02/08/2012 | EP2413968A1 Semaphorin 3c (sema3c) inhibitor therapeutics, methods, and uses |
02/08/2012 | EP2413966A1 Combination therapy of an afucosylated antibody and one or more of the cytokines selected from human gm-csf, human m-csf and/or human il-3 |
02/08/2012 | EP2413958A1 Cytokines and neuroantigens for treatment of immune disorders |
02/08/2012 | EP2413955A2 N-terminus conformationally constrained glp-1 receptor agonist compounds |
02/08/2012 | EP2413954A1 Compositions and methods for treatment of aortic fibrosis |
02/08/2012 | EP2413953A2 Methods for preparing and using multichaperone-antigen complexes |
02/08/2012 | EP2413952A1 Improvement in promotion of healthy catch-up growth |
02/08/2012 | EP2413951A2 Formulation for inducing broadly reactive neutralizing anti-hiv antibodies |
02/08/2012 | EP2413950A2 Antigenic peptide of hsv-2 and methods for using same |
02/08/2012 | EP2413949A2 Inhibition of biofilm organisms |
02/08/2012 | EP2413947A1 Methods and compositions for treating skin conditions associated with vascular hyper-reactivity |
02/08/2012 | EP2413904A1 Protein-assisted drug delivery system for the targeted administration of active agents for overcoming blood-brain barrier |
02/08/2012 | EP2413903A1 Pulmonary and nasal delivery of serum amyloid p |
02/08/2012 | EP2413891A2 Novel proteasome-activating anti-aging peptides and compositions containing same |
02/08/2012 | EP2413720A1 Process for making a milk-based protein hydrolysate |
02/08/2012 | EP2413694A1 A peg-albumin composition having at least one protected thiol region as a platform for medications |
02/08/2012 | EP2288372B1 An il-2 mutant for use in the treatment or prophylaxis of autoimmune disease |
02/08/2012 | EP2195014B1 Use of g-csf for the treatment of stroke |
02/08/2012 | EP2152288B1 Reconstituted surfactants having improved properties |
02/08/2012 | EP2102235B1 Treatment of cachexia |
02/08/2012 | EP2075004B1 Use of epidermal growth factor for the morphofunctional restoration of peripheral nerves in diabetic neuropathy |
02/08/2012 | EP2010562B1 Novel polypeptides inducing dendritic cell migration, as well as medicines and pharmaceutical compositions containing same |
02/08/2012 | EP1933809B1 Compositions for nasal delivery |
02/08/2012 | EP1902141B1 Adamts13-comprising compositions having thrombolytic activity |
02/08/2012 | EP1824882B1 Osteoprotegerin variant proteins |
02/08/2012 | EP1817047B1 Use of scf and g-csf in the treatment of cerebral ischemia and neurological disorders |
02/08/2012 | EP1711531B1 Neutralizing anti tlr4/md-2 antibodies and methods of use thereof |
02/08/2012 | EP1682074B1 Compositions and methods for healthy pregnancy |
02/08/2012 | EP1620468B1 Fusion polypeptide suitable as a cytotoxin |
02/08/2012 | EP1608393B1 Ebola peptides and immunogenic compositions containing same |
02/08/2012 | EP1562631B1 Bowman-birk inhibitor concentrate product and process |
02/08/2012 | EP1545557B1 Combination therapies with l-fmau for the treatment of hepatitis b virus infection |
02/08/2012 | EP1537203B1 USE OF DENDRITIC CELLS (DCs) EXPRESSING INTERLEUKIN 12 (IL-12) |
02/08/2012 | EP1416972B1 Chimeric molecules to modulate gene expression |
02/08/2012 | EP0971958B2 Method for purifying factor viii/vwf complex by cation-exchange chromatography |
02/08/2012 | CN1758900B 药物组合物 The pharmaceutical composition of |
02/08/2012 | CN102348723A Peptide therapeutic conjugates and uses thereof |
02/08/2012 | CN102348721A Complex and production process |
02/08/2012 | CN102348720A Compositions and methods for prevention and treatment of neurodegenerative diseases |
02/08/2012 | CN102348718A Deoxyactagardine derivatives |
02/08/2012 | CN102348465A Ameliorating agent for chronic obstructive pulmonary disease |
02/08/2012 | CN102348464A Injectable biomaterials |
02/08/2012 | CN102348463A Prevention and/or treatment of multiple organ dysfunction syndrome with interleukin-22 |
02/08/2012 | CN102348462A Tfpi inhibitors and methods of use |
02/08/2012 | CN102348454A Oil-based preparation containing antiprotozoal triazines and anthelmintic cyclodepsipeptides |
02/08/2012 | CN102348387A Method for production of lactoferrin |
02/08/2012 | CN102344489A Modified sodium iodine symporter protein and application thereof |
02/08/2012 | CN102344485A Peptide beta secretase inhibitor for treating alzheimer's disease, and use thereof |
02/08/2012 | CN102343102A Application of activin receptor-interacting protein 2 (ARIP2) gene to preparation of medicament |
02/08/2012 | CN102343091A Ezrin phosphorylation-based material and application thereof |
02/08/2012 | CN102343085A Oil in water (O/W) emulsion for treating skin trauma and preparation method of oil in water emulsion |
02/08/2012 | CN102343084A Amylin and amylin agonists for treating psychiatric diseases and disorders |
02/08/2012 | CN102343083A Antivirus composition medicament |
02/08/2012 | CN102342923A Biological enzyme chewing gum and preparation method thereof |
02/08/2012 | CN102342920A Pharmaceutical composition containing alarelin acetate and preparation method thereof |
02/08/2012 | CN102342918A Colon-targeting coating system, colon-targeting oral preparation and preparation method of colon-targeting oral preparation |
02/08/2012 | CN102342915A Method for preparing antihypertensive peptide microsphere with intestine site-specific delivery drugs release effect |
02/08/2012 | CN102342913A Intra-intestinal nutrient emulsion for tumor patients and preparation method thereof |
02/08/2012 | CN102342908A 胶原蛋白角膜 Corneal Collagen |